Company · CIK 0001226616 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MEDICINOVA INC · MNOV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 MForm 4 → | Mar 4, 6:00 am EST | Masatsune OkajimaVP and Head of Japanese Office | 886,950 | $4.19 | $3,718,763 | 1,040,530 | — | plan? |
| Jan 9, 2019 MForm 4 → | Jan 11, 4:24 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 41,250 | $2.20 | $90,750 | 153,580 | — | plan? |
| Jan 3, 2019 MForm 4 → | Jan 7, 6:04 am EST | Yuichi IwakiPresident and CEO, Director | 18,572 | $2.20 | $40,858 | 759,392 | — | plan? |
| Mar 5, 2018 MForm 4 → | Mar 7, 4:31 pm EST | Yuichi IwakiPresident and CEO, Director | 50,003 | $2.20 | $110,007 | 740,594 | — | plan? |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:51 pm EST | Yuichi IwakiPresident and CEO, Director | 53,363 | $4.42 | $235,864 | 690,591 | — | plan? |
| Dec 12, 2017 MForm 4 → | Dec 14, 3:03 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 48,000 | $4.42 | $212,160 | 108,941 | — | plan? |
| Nov 2, 2017 MForm 4 → | Nov 6, 8:15 am EST | Yuichi IwakiPresident and CEO, Director | 21,067 | $4.42 | $93,116 | 637,228 | — | plan? |
| Aug 21, 2017 PForm 4 → | Aug 23, 1:50 pm EDT | Yoshio IshizakaDirector | 5,000 | $5.17 | $25,850 | 10,000 | +100% | plan? |
| May 15, 2017 PForm 4 → | May 16, 2:52 pm EDT | Yutaka KobayashiDirector | 1,000 | $5.60 | $5,600 | 25,000 | +4.17% | plan? |
| May 12, 2017 PForm 4 → | May 15, 6:27 pm EDT | Yutaka KobayashiDirector | 24,000 | $5.62 | $134,880 | 24,000 | — | plan? |
| Sep 15, 2016 PForm 4 → | Sep 15, 2:10 pm EDT | Yutaka KobayashiDirector | 11,800 | $6.44 | $75,992 | 81,800 | +16.9% | plan? |
| Sep 9, 2016 PForm 4 → | Sep 9, 6:29 pm EDT | Yutaka KobayashiDirector | 10,000 | $6.67 | $66,700 | 70,000 | +16.7% | plan? |
| Jul 5, 2016 SForm 4 → | Jul 7, 6:30 pm EDT | Geoffrey OBrienVice President | 3,300 | $8.00 | $26,400 | 5,000 | −39.8% | plan? |
| Jul 5, 2016 MForm 4 → | Jul 7, 6:30 pm EDT | Geoffrey OBrienVice President | 3,300 | $4.80 | $15,840 | 8,300 | — | plan? |
| Mar 14, 2016 XForm 4 → | Mar 16, 6:25 pm EDT | Kazuko MatsudaChief Medical Officer | 800 | $3.56 | $2,848 | 62,003 | — | plan? |
| Mar 14, 2016 XForm 4 → | Mar 16, 6:25 pm EDT | Masatsune OkajimaVP and Head of Japanese Office | 8,400 | $3.56 | $29,904 | 51,138 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 AForm 4 → | Jun 25, 4:38 pm EDT | Hideki NagaoDirector | 44,500 | — | — | 44,500 | — | |
| Jun 23, 2026 AForm 4 → | Jun 25, 4:35 pm EDT | Nicole LemerondDirector | 44,500 | — | — | 44,500 | — | |
| Jun 23, 2026 AForm 4 → | Jun 25, 4:35 pm EDT | Carolyn BeaverDirector | 44,500 | — | — | 44,500 | — | |
| Feb 28, 2019 MForm 4 → | Mar 4, 6:00 am EST | Masatsune OkajimaVP and Head of Japanese Office | 886,950 | — | — | 0 | — | |
| Jan 15, 2019 AForm 4 → | Jan 17, 4:24 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 105,000 | — | — | 105,000 | — | |
| Jan 15, 2019 AForm 4 → | Jan 17, 4:23 pm EST | Geoffrey OBrienVice President | 205,000 | — | — | 205,000 | — | |
| Jan 15, 2019 AForm 4 → | Jan 17, 4:23 pm EST | Kazuko MatsudaChief Medical Officer | 295,000 | — | — | 295,000 | — | |
| Jan 15, 2019 AForm 4 → | Jan 17, 4:22 pm EST | Yuichi IwakiPresident and CEO, Director | 470,000 | — | — | 470,000 | — | |
| Jan 9, 2019 MForm 4 → | Jan 11, 4:24 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 41,250 | — | — | 0 | — | |
| Jan 3, 2019 MForm 4 → | Jan 7, 6:04 am EST | Yuichi IwakiPresident and CEO, Director | 18,572 | — | — | 0 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 4:08 pm EDT | Hideki NagaoDirector | 20,000 | — | — | 20,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 4:07 pm EDT | Yutaka KobayashiDirector | 20,000 | — | — | 20,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 4:07 pm EDT | Yoshio IshizakaDirector | 20,000 | — | — | 20,000 | — | |
| Mar 5, 2018 MForm 4 → | Mar 7, 4:31 pm EST | Yuichi IwakiPresident and CEO, Director | 50,003 | — | — | 0 | — | |
| Jan 6, 2018 AForm 4 → | Jan 9, 6:25 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 100,000 | — | — | 100,000 | — | |
| Jan 6, 2018 AForm 4 → | Jan 9, 6:24 pm EST | Geoffrey OBrienVice President | 200,000 | — | — | 200,000 | — | |
| Jan 6, 2018 AForm 4 → | Jan 9, 6:23 pm EST | Kazuko MatsudaChief Medical Officer | 280,000 | — | — | 280,000 | — | |
| Jan 6, 2018 AForm 4 → | Jan 9, 6:12 pm EST | Yuichi IwakiPresident and CEO, Director | 450,000 | — | — | 450,000 | — | |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:51 pm EST | Yuichi IwakiPresident and CEO, Director | 53,363 | — | — | 0 | — | |
| Dec 12, 2017 MForm 4 → | Dec 14, 3:03 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 48,000 | — | — | 0 | — | |
| Nov 9, 2017 AForm 4 → | Nov 13, 5:34 pm EST | Hideki NagaoDirector | 35,000 | — | — | 15,000 | — | |
| Nov 2, 2017 MForm 4 → | Nov 6, 8:15 am EST | Yuichi IwakiPresident and CEO, Director | 21,067 | — | — | 0 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:22 pm EDT | Yutaka KobayashiDirector | 20,000 | — | — | 20,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:21 pm EDT | Yoshio IshizakaDirector | 20,000 | — | — | 20,000 | — | |
| Jan 18, 2017 AForm 4 → | Jan 20, 5:31 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 120,000 | — | — | 120,000 | — | |
| Jan 18, 2017 AForm 4 → | Jan 20, 5:30 pm EST | Geoffrey OBrienVice President | 115,000 | — | — | 115,000 | — | |
| Jan 18, 2017 AForm 4 → | Jan 20, 5:29 pm EST | Kazuko MatsudaChief Medical Officer | 170,000 | — | — | 170,000 | — | |
| Jan 18, 2017 AForm 4 → | Jan 20, 5:28 pm EST | Yuichi IwakiPresident and CEO, Director | 320,000 | — | — | 320,000 | — | |
| Jul 5, 2016 MForm 4 → | Jul 7, 6:30 pm EDT | Geoffrey OBrienVice President | 3,300 | — | — | 21,700 | — | |
| Jun 9, 2016 AForm 4 → | Jun 13, 1:37 pm EDT | Yoshio IshizakaDirector | 20,000 | — | — | 20,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 13, 1:36 pm EDT | Yutaka KobayashiDirector | 20,000 | — | — | 20,000 | — | |
| Mar 14, 2016 XForm 4 → | Mar 16, 6:25 pm EDT | Kazuko MatsudaChief Medical Officer | 800 | — | — | 0 | — | |
| Mar 14, 2016 XForm 4 → | Mar 16, 6:25 pm EDT | Masatsune OkajimaVP and Head of Japanese Office | 8,400 | — | — | 0 | — | |
| Jan 20, 2016 PForm 4 → | Jan 21, 5:46 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 8,400 | — | — | 8,400 | — | |
| Jan 20, 2016 SForm 4 → | Jan 21, 5:45 pm EST | Kazuko MatsudaChief Medical Officer | 8,400 | — | — | 800 | — | |
| Jan 7, 2016 AForm 4/A → | Jan 19, 6:29 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 135,000 | — | — | 30,000 | — | |
| Jan 7, 2016 AForm 4/A → | Jan 19, 6:28 pm EST | Geoffrey OBrienVice President | 135,000 | — | — | 30,000 | — | |
| Jan 7, 2016 AForm 4/A → | Jan 19, 6:27 pm EST | Kazuko MatsudaChief Medical Officer | 225,000 | — | — | 100,000 | — | |
| Jan 7, 2016 AForm 4/A → | Jan 19, 6:26 pm EST | Yuichi IwakiPresident and CEO, Director | 370,000 | — | — | 120,000 | — | |
| Jan 7, 2016 AForm 4 → | Jan 11, 6:56 pm EST | Masatsune OkajimaVP and Head of Japanese Office | 135,000 | — | — | 30,000 | — | amended |
| Jan 7, 2016 AForm 4 → | Jan 11, 6:55 pm EST | Geoffrey OBrienVice President | 135,000 | — | — | 30,000 | — | amended |
| Jan 7, 2016 AForm 4 → | Jan 11, 6:55 pm EST | Kazuko MatsudaChief Medical Officer | 225,000 | — | — | 100,000 | — | amended |
| Jan 7, 2016 AForm 4 → | Jan 11, 6:53 pm EST | Yuichi IwakiPresident and CEO, Director | 370,000 | — | — | 120,000 | — | amended |
| Jul 9, 2015 AForm 4 → | Jul 13, 2:55 pm EDT | Yutaka KobayashiDirector | 20,000 | — | — | 20,000 | — | |
| Jul 9, 2015 AForm 4 → | Jul 13, 2:54 pm EDT | Yoshio IshizakaDirector | 20,000 | — | — | 20,000 | — |